Atlas Genetics Inc

Factor Bioscience Inc., located in Cambridge, MA, is devoted to advancing cell engineering to address diseases and elevate health standards. With over a decade of experience and a robust portfolio of more than 150 patents, the company focuses on developing transformative allogeneic cell therapies leveraging innovative technologies in mRNA gene editing, cell reprogramming, and nucleic acid delivery. The organization emphasizes collaboration with strategic partners throughout all stages of product development, from initial research to manufacturing support. Factor Bioscience aims to harness the potential of cell engineering in revolutionizing medicine for millions of patients, believing that their work can significantly impact the treatment and management of various health conditions, including cancer and rare diseases. Generated from the website

Prime Medicine, Inc., based in Cambridge, MA, is dedicated to transforming the lives of patients suffering from debilitating diseases through its innovative Prime Editing platform. This next-generation gene editing technology aims to address the genetic causes of diseases by precisely editing and replacing faulty DNA segments, potentially offering long-lasting cures. With the capability to theoretically target about 90% of known disease-causing mutations across various organisms, organs, and cell types, Prime Editing is designed to work broadly while minimizing unwanted DNA modifications. The company envisions a future where this versatile and efficient approach significantly impacts the treatment of diseases, ultimately enhancing patient outcomes and shaping the landscape of gene editing. Generated from the website

BGI Americas Corporation, based in Cambridge, MA, is the largest genomics center in the world, providing comprehensive sequencing and bioinformatics services for medical, agricultural, and environmental applications. The company is recognized globally for its innovative collaborative projects and strong scientific expertise, supported by over 900 publications in prestigious journals. Dedicated to helping customers achieve their research goals, BGI delivers rapid, high-quality results using a diverse array of cost-effective, cutting-edge technologies. Their commitment to advancing scientific knowledge and improving health outcomes is reflected in their international partnerships and ongoing research initiatives. Generated from the website